top of page
Our Company
Blurred Motion

About Us

Founded in 2019 by a team of entrepreneurs and surgeons from Washington University in St. Louis, Caeli

Vascular Inc., has developed the SUMMIT™ Multi-Modal technology platform for the treatment of thrombotic disease. SUMMIT™'s patented therapeutic bundle is both comprehensive and transformative and establishes a new paradigm for the treatment of multiple thrombotic diseases. 

Caeli Vascular's SHIELD™ Thrombectomy System is the first product developed on this platform and will target large volume Deep Vein Thrombosis (DVT). SHIELD™ is designed to provide better patient outcomes in a single device/single session setting to dramatically reduce device utilization, lower costs and increase profitability to healthcare institutions.

Diverse multiracial medical team consult
Diverse multiracial medical team consult

Our Team

bottom of page